Central Serous Chorioretinopathy: Multimodal Imaging and Management Options. (14th August 2020)

• Record Type: Journal Article
• Authors: Iyer, Prashanth G.; Schwartz, Stephen G.; Russell, Jonathan F.; Flynn, Harry W.
• Other Names: Machida Shigeki Academic Editor.
• Is Part Of: Case reports in ophthalmological medicine. Volume 2020(2020)
• Publication Date: 2020-08-14
• Subjects: Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Ophthalmology; Eye Diseases; Eye -- Diseases; Ophthalmology; Electronic journals; Periodicals; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 617.7
• DOI: 10.1155/2020/8890404
• Languages: English
• ISSNs: 2090-6722

Abstract

Abstract : Central serous chorioretinopathy (CSCR) is an idiopathic maculopathy characterized by thickened choroid, retinal pigment epithelial detachment, and variable subretinal fluid. CSCR predominantly affects young men, with risk factors including corticosteroid use, the type A behavior pattern, and psychological stress. While usually self-limited with a good visual prognosis, recurrent and persistent CSCR can lead to outer retinal and/or retinal pigment epithelial atrophy, choroidal neovascularization, and visual loss. This article reviews current multimodal imaging and treatment options, which include observation, mineralocorticoid receptor antagonists, thermal laser photocoagulation, and off-label photodynamic therapy with verteporfin.